https://www.epmmagazine.com/topics/headline/index.rss en-gb © 2020 Rapid Life Sciences Ltd, a Rapid News Group Company. All Rights Reserved. Mon, 26 Dec 2016 09:00:00 -0000 To satisfy his inner geek, our editor Dave Gray takes a dive into the world of web traffic analytics to see which EPM online stories you were reading over the past 12 months. https://www.epmmagazine.com/news/2016-digital-highlights/ https://www.epmmagazine.com/news/2016-digital-highlights/ Mon, 26 Dec 2016 09:00:00 -0000 12 Months in Headlines £16 million has been awarded to university-led projects for the development of molecular pathology tests that help deliver stratified medicine. https://www.epmmagazine.com/news/six-pathology-testing-projects/ https://www.epmmagazine.com/news/six-pathology-testing-projects/ Mon, 27 Jul 2015 12:05:00 -0000 Red blood cells US-based organisation SumOfUs has produced a report that states a frequently overlooked cause of AMR is environmental pollution related to the production of antibiotic intermediates and APIs for antibiotic drugs. https://www.epmmagazine.com/news/sumofus-calls-for-clean-up-of-antibiotics-supply-chain/ https://www.epmmagazine.com/news/sumofus-calls-for-clean-up-of-antibiotics-supply-chain/ Tue, 21 Jul 2015 11:07:00 -0000 Antibiotics The All-Party Parliamentary Group on Life Sciences is holding its launch event today in Parliament. The group's purpose is to raise understanding of the valuable contribution the life sciences sector provides to the health and wealth of the nation. https://www.epmmagazine.com/news/appg-to-raise-life-sciences-profile/ https://www.epmmagazine.com/news/appg-to-raise-life-sciences-profile/ Mon, 20 Jul 2015 12:48:00 -0000 Parliament A new study led by the University of Edinburgh, in collaboration with the Universities of Warwick, Sheffield and Liverpool, has revealed that treating obese pregnant women with a diabetes drug does not stop their babies from being born overweight. https://www.epmmagazine.com/news/study-finds-diabetes-drug-has-no-effect-on-birthweights/ https://www.epmmagazine.com/news/study-finds-diabetes-drug-has-no-effect-on-birthweights/ Fri, 10 Jul 2015 08:00:00 -0000 Pregnancy scan The FDA has accepted an investigator-sponsored investigational new drug application for a Phase IIA clinical trial for the potential treatment of milk-induced eosinophilic esophagitis in children using DBV Technologies' Viaskin milk. https://www.epmmagazine.com/news/ind-acceptance-for-milk-induced-eoe-treatment/ https://www.epmmagazine.com/news/ind-acceptance-for-milk-induced-eoe-treatment/ Wed, 08 Jul 2015 15:49:00 -0000 Milk allergy Sanofi will extend its alliance with Medicines for Malaria Venture to jointly develop a fixed-dose combination therapy for malaria, the deadliest parasitic disease in the world. https://www.epmmagazine.com/news/sanofi-and-mmv-to-develop-malaria-therapy/ https://www.epmmagazine.com/news/sanofi-and-mmv-to-develop-malaria-therapy/ Wed, 08 Jul 2015 08:22:00 -0000 Malaria A white paper entitled ‘Abuse Deterrence for the Pharmaceutical Market?’ has been published by materials technology company Lucideon. https://www.epmmagazine.com/news/lucideon-publishes-paper-on-pharmaceutical-abuse-deterrence/ https://www.epmmagazine.com/news/lucideon-publishes-paper-on-pharmaceutical-abuse-deterrence/ Tue, 07 Jul 2015 11:38:00 -0000 pillsspillbottl.jpg Following the successful launch of its PIPETGIRL pink pipette controller in support of breast cancer research, INTEGRA Biosciences has made a $10,000 donation to the Susan F Smith Center for Womens Cancers at the Dana-Farber Cancer Institute. https://www.epmmagazine.com/news/integra-donates-10000-to-dana-farber-cancer-institute/ https://www.epmmagazine.com/news/integra-donates-10000-to-dana-farber-cancer-institute/ Tue, 07 Jul 2015 10:31:00 -0000 INTEGRA The Ministry of Health, Labor and Welfare in Japan has granted marketing authorisation for Sanofi's insulin glargine [rDNA origin] injection, 300 u/ml, a next-generation basal insulin for the treatment of type 1 and type 2 diabetes mellitus. https://www.epmmagazine.com/news/japan-approves-sanofis-insulin-injection-for-diabetes-mellitus/ https://www.epmmagazine.com/news/japan-approves-sanofis-insulin-injection-for-diabetes-mellitus/ Mon, 06 Jul 2015 11:51:00 -0000 injectioninarm.jpg £16.9 million is being invested by Teva Pharmaceutical Industries and Philips in a joint venture that supports medical device and health technology start-ups in Israel over the next eight years. https://www.epmmagazine.com/news/sanara-ventures-israeli-medical-device/ https://www.epmmagazine.com/news/sanara-ventures-israeli-medical-device/ Thu, 02 Jul 2015 11:20:00 -0000 Sanara Ventures Late clinical-stage nanomedicine company Nanobiotix has been authorised to begin a new clinical trial in liver cancers for its lead NanoXray product, NBTXR3. https://www.epmmagazine.com/news/nanobiotix-clinical-trial-nanoxray-liver-cancers/ https://www.epmmagazine.com/news/nanobiotix-clinical-trial-nanoxray-liver-cancers/ Thu, 02 Jul 2015 10:41:00 -0000 NANOBIOTIX CEA-Leti has announced the creation of the European Nano-Characterisation Laboratory (EU-NCL), funded by the European Union’s Horizon 2020 research and innovation programme. https://www.epmmagazine.com/news/european-nanomedicine-characterisation-laboratory/ https://www.epmmagazine.com/news/european-nanomedicine-characterisation-laboratory/ Wed, 01 Jul 2015 14:37:00 -0000 Nanomedicine A new pharmaceutical spray-dried dispersion commercial manufacturing facility at Capsugel's site in Bend, Ore, US, is ready for business. https://www.epmmagazine.com/news/new-commercial-sdd-facility-does-capsugel-proud/ https://www.epmmagazine.com/news/new-commercial-sdd-facility-does-capsugel-proud/ Tue, 30 Jun 2015 16:18:00 -0000 Capsugel SDD A €1.8m frozen and chilled storage facility has been constructed by IDS Solutions for Spanish pharmaceutical and healthcare giant Grifols. https://www.epmmagazine.com/news/isd-completes-cold-storage-facility-for-pharma-giant-grifols/ https://www.epmmagazine.com/news/isd-completes-cold-storage-facility-for-pharma-giant-grifols/ Tue, 30 Jun 2015 11:49:00 -0000 IDS Solutions Nordic Life Science Days has announced that the region's premier life sciences event is on course for a record number of attendees. https://www.epmmagazine.com/news/record-numbers-expected-at-nls-days/ https://www.epmmagazine.com/news/record-numbers-expected-at-nls-days/ Tue, 30 Jun 2015 10:43:00 -0000 Conference A rapid test for Ebola has been developed by the BBI Group (BBI) in collaboration with the Defence Science and Technology Laboratory (Dstl) and licensed through technology transfer company Ploughshare Innovations. https://www.epmmagazine.com/news/bbi-test-diagnoses-ebola-in-20-minutes/ https://www.epmmagazine.com/news/bbi-test-diagnoses-ebola-in-20-minutes/ Mon, 29 Jun 2015 16:10:00 -0000 BBI Ebola test Novartis International will acquire Spinifex Pharmaceuticals, a developer of drugs for chronic pain, for an upfront cash consideration of $200 million, plus undisclosed clinical development and regulatory milestone payments. https://www.epmmagazine.com/news/spinifex-pharmaceuticals-to-be-bought-by-novartis/ https://www.epmmagazine.com/news/spinifex-pharmaceuticals-to-be-bought-by-novartis/ Mon, 29 Jun 2015 09:23:00 -0000 Tablets Aeterna Zentaris has selected Ergomed to manage the confirmatory Phase 3 clinical study demonstrating the efficacy of Macrilen (macimorelin), a novel orally-active ghrelin agonist for use in evaluating adult growth hormone deficiency. https://www.epmmagazine.com/news/ergomed-to-conduct-trial-of-macimorelin/ https://www.epmmagazine.com/news/ergomed-to-conduct-trial-of-macimorelin/ Thu, 25 Jun 2015 15:21:00 -0000 tablets.jpg New Zealand kanuka honey formulation Honevo gives renewed hope to the 5–10% of adults who suffer from rosacea after a large clinical trial proved it an effective and safe treatment of the condition. https://www.epmmagazine.com/news/new-zealand-honey-product-proven-to-help-treat-rosacea/ https://www.epmmagazine.com/news/new-zealand-honey-product-proven-to-help-treat-rosacea/ Thu, 25 Jun 2015 10:55:00 -0000 Honey A fully integrated antibody drug conjugate (ADC) facility is to be built at Novasep's Le Mans site in France, complementing the company's current ADC offering with full bioconjugation services to meet increasing market demand. https://www.epmmagazine.com/news/10m-facility-reinforces-novaseps-commitment-to-bioconjugation/ https://www.epmmagazine.com/news/10m-facility-reinforces-novaseps-commitment-to-bioconjugation/ Thu, 25 Jun 2015 09:49:00 -0000 Antibody drug conjugate BioNTech RNA Pharmaceuticals and EUFETS will work with Siemens to produce a fully automated and digitalised production site, providing capacity for BioNTech’s personalised cancer vaccines to serve worldwide markets. https://www.epmmagazine.com/news/siemens-and-biontech-personalised-cancer-vaccines-coop/ https://www.epmmagazine.com/news/siemens-and-biontech-personalised-cancer-vaccines-coop/ Thu, 25 Jun 2015 08:58:05 -0000 Personalised medicine Emily Hughes The life and health sciences industry is worth £50 billion a year to the British economy, and employs 175,000 people, one estimate says. https://www.epmmagazine.com/news/britain-could-lead-the-global-race-in-life-sciences/ https://www.epmmagazine.com/news/britain-could-lead-the-global-race-in-life-sciences/ Mon, 22 Jun 2015 15:33:00 -0000 Flag Money Stethescope.jpg Johnson & Johnson's Janssen Biotech is to deploy Emulate’s organs-on-chips platform to better predict the potential human response of drug candidates and improve the drug development process under a recently formed research collaboration. https://www.epmmagazine.com/news/emulate-organs-on-chips/ https://www.epmmagazine.com/news/emulate-organs-on-chips/ Fri, 19 Jun 2015 11:00:00 -0000 Emulate Analytical and bioanalytical contract solutions provider SGS Life Science Services is gearing up for the 9 June opening of its new bio/pharma quality control laboratory at Villeneuve La Garenne, a Paris suburb, replacing the existing Clichy facility. https://www.epmmagazine.com/news/sgs-life-science-services-new-lab/ https://www.epmmagazine.com/news/sgs-life-science-services-new-lab/ Wed, 17 Jun 2015 09:49:52 -0000 Clinical lab Merck Millipore has launched the Mobius 2000 litre single-use bioreactor at Achema - and is offering live demonstrations on the stand. https://www.epmmagazine.com/technology/merck-unveils-huge-bioreactor-at-achema/ https://www.epmmagazine.com/technology/merck-unveils-huge-bioreactor-at-achema/ Tue, 16 Jun 2015 09:39:00 -0000 Bioreactor 3.jpg The Additive Manufacturing and 3D Printing Research Group has unveiled its new lab, dedicated to research and testing of new materials for 3D printing and their practical applications, alongside exciting developments in multifunctional 3D printing. https://www.epmmagazine.com/news/uni-of-nottingham-3d-printed-drugs/ https://www.epmmagazine.com/news/uni-of-nottingham-3d-printed-drugs/ Tue, 16 Jun 2015 08:55:00 -0000 3D.jpg Packaging machinery group Uhlmann launched (in style) BLU 400 at Achema today, its new blister machine for start-to-finish packaging of syringes, ampoules, vials, cartridges, and bottles. https://www.epmmagazine.com/technology/uhlmann-blu-400-achema/ https://www.epmmagazine.com/technology/uhlmann-blu-400-achema/ Mon, 15 Jun 2015 14:28:00 -0000 IMAG1852.jpg Speaking at this year's Achema trade show in Frankfurt, Bosch Packaging Technology reported strong growth in 2014, with further positive signs for this year. https://www.epmmagazine.com/news/bosch-achema-2015/ https://www.epmmagazine.com/news/bosch-achema-2015/ Mon, 15 Jun 2015 13:53:00 -0000 Bosch at Achema 2015 Cell therapies developer Plasticell has recruited Dr. Aaron Chuang chief scientific officer (CSO). Dr. Chuang takes on responsibility for preclinical therapeutic programmes and scientific oversight of collaborations and alliances, as well as external https://www.epmmagazine.com/news/plasticell-appoints-cso/ https://www.epmmagazine.com/news/plasticell-appoints-cso/ Mon, 15 Jun 2015 09:02:00 -0000 Cell therapy